Preterm infants with respiratory distress syndrome (RDS) face heightened risks of death, critical illness, and prolonged hospitalization, particularly if they progress to develop acute respiratory ...
Pulmonary surfactants are a complex assembly of lipids and proteins that play a critical role in maintaining the stability of the alveolar air–liquid interface during breathing. Their primary function ...
The Lundquist Institute (TLI) and The Bill & Melinda Gates Medical Research Institute (Gates MRI) executed a license agreement for TLI intellectual property covering a synthetic lung surfactant ...
Newborns who lack natural surfactants develop respiratory distress syndrome. Surfactants are materials that reduce liquid surface tension, enabling carbon dioxide and oxygen to easily exchange as ...
HealthDay News — The FDA has approved Surfaxin (lucinactant) to prevent respiratory distress syndrome (RDS) in premature infants. Premature infants born before 37 weeks’ gestation often cannot produce ...
Higher body mass index (BMI) at the start of pregnancy is associated with increased risk for adverse maternal outcomes, including preeclampsia, and neonatal complications, such as respiratory distress ...
The report is the first recorded case of acute respiratory distress syndrome (ARDS) that required venovenous extracorporeal membrane oxygenation and was complicated by spontaneous spleen rupture. RUX, ...
The rationale for subphenotyping acute respiratory distress syndrome (ARDS) arises from its marked biological and clinical ...
Acute respiratory distress syndrome (ARDS) is a potentially fatal condition where the lungs cannot provide enough oxygen to the body's vital organs. The condition, otherwise known as acute lung injury ...
Researchers at Endeavor Health and Northwestern University have created an artificial intelligence-based tool to help doctors recognize an underdiagnosed, often fatal respiratory syndrome found in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results